Trials / Terminated
TerminatedNCT01305122
Tumor and Treatments Impact on Neurocognitive Functions and Quality of Life of Patients With OMS Grade II Glioma
Tumor and Treatments Impact on Neurocognitive Functions and Quality of Life of Patients With OMS Grade II Glioma: Multicentric Prospective Study
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 112 (actual)
- Sponsor
- Centre Leon Berard · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a multicenter prospective study:2 independant cohorts of patients with OMS grade II glioma will be followed during 5 years. * cohort A: patients in first-line treatment (surgery, radiotherapy or chemotherapy) * cohort B: patients with disease simple monitoring. The primary endpoint is to evaluate the impact of tumor and treatments on neurocognitive functions and quality of life, using validate and standard tests.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | neurocognitive tests | * inclusion * 1 year * 3 years * 5 years |
Timeline
- Start date
- 2011-02-01
- Primary completion
- 2018-10-21
- Completion
- 2018-10-21
- First posted
- 2011-02-28
- Last updated
- 2021-02-09
Locations
21 sites across 1 country: France
Source: ClinicalTrials.gov record NCT01305122. Inclusion in this directory is not an endorsement.